The Trendlines Group Ltd. Files Final Prospectus and Announces Pricing for Initial Public Offering of Ordinary Shares
The Trendlines Group Ltd. ("Trendlines" or the "Company") has filed a final prospectus with the securities regulatory authorities in Ontario, British Columbia, Alberta, Saskatchewan, Manitoba and Nova Scotia in connection with the initial public offering (the "Offering") of its ordinary shares. A copy of the final prospectus is available on the SEDAR website at www.sedar.com.
The Company also announced the pricing of its Offering of up to 2,638,889 ordinary shares at a price of Cdn$3.60 per share for gross proceeds of Cdn$9.5 million. The agents have been granted an option to purchase up to an additional 395,833 Ordinary Shares in an over-allotment option; should the over-allotment be fully exercised, total gross proceeds from the offering will be $10.925 million.
The offering is being made on a best efforts agency basis led by Octagon Capital Corporation and including Euro Pacific Canada Inc., Paradigm Capital Inc. and M Partners Inc.
Closing is scheduled to take place on or about September 30, 2014.
Trendlines has received conditional approval to list its ordinary shares on the Toronto Stock Exchange under the symbol ("TLG") subject to the Company fulfilling all of the requirements of the Toronto Stock Exchange.
No securities regulatory authority has either approved or disapproved the contents of this press release. This press release does not constitute an offer to sell or a solicitation of an offer to buy any securities of The Trendlines Group Ltd. in any jurisdiction in which such offer, solicitation or sale would be unlawful. These securities have not been and will not be registered under the United States Securities Act of 1933, as amended, or any U.S. state securities law and may not be offered or sold in the United States except in compliance with the registration requirements of said Act and applicable U.S. state securities laws or pursuant to an exemption therefrom. The Trendlines Group Ltd. has not and will not take any action, which would require it to publish a prospectus in accordance with, and subject to, the Israeli Securities Law 5728-1968 and the regulations promulgated thereunder (the "Israeli Securities Law"). These securities have not been and will not be registered under the Israeli Securities Law and may not be offered or sold in the State of Israel except pursuant to an exemption thereunder from prospectus or registration requirements and in compliance therewith.
About The Trendlines Group Ltd.
Trendlines creates and develops companies in accordance with its mission to improve the human condition. To that end, it discovers, invests in, incubates and provides services to, medical and agricultural technology companies, all of which are based in Israel. The Company also has its own internal invention center, Trendlines Labs, where it creates new technologies, either as principal or in collaboration with global companies and partners to address unmet market needs. www.trendlines.com.
(416) 367-5000 ext. 2226